ErbB2 blockade with Herceptin (trastuzumab) enhances peripheral nerve regeneration after repair of acute or chronic peripheral nerve injury

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Annals of Neurology

• Publication date

  2016-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ana.24688PMID 27159537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Side-To-Side Nerve Bridges Support Donor Axon Regeneration Into Chronically Denervated Nerves and Are Associated With Characteristic Changes in Schwann Cell Phenotype.

  2015cited by this paper
• Nerve Cross-Bridging to Enhance Nerve Regeneration in a Rat Model of Delayed Nerve Repair

  2015cited by this paper
• The ErbB2 inhibitor Herceptin (Trastuzumab) promotes axonal outgrowth four weeks after acute nerve transection and repair.

  2014cited by this paper
• ErbB1 epidermal growth factor receptor is a valid target for reducing the effects of multiple inhibitors of axonal regeneration

  2013cited by this paper
• Schwann cell phenotype is regulated by axon modality and central-peripheral location, and persists in vitro.

  2013cited by this paper
• GDNF released from microspheres enhances nerve regeneration after delayed repair

  2012cited by this paper
• Potential of afatinib in the treatment of patients with HER2-positive breast cancer.

  2012cited by this paper
• Side-to-Side Nerve Grafts Sustain Chronically Denervated Peripheral Nerve Pathways During Axon Regeneration and Result in Improved Functional Reinnervation

  2011cited by this paper
• Axonally Derived Neuregulin-1 Is Required for Remyelination and Regeneration after Nerve Injury in Adulthood

  2011cited by this paper
• Pathophysiology of Surgical Nerve Disorders

  2011cited by this paper
• Mechanics of EGF Receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging

  2011cited by this paper
• A New Model for Facial Nerve Research

  2010cited by this paper
• The role of neurotrophic factors in nerve regeneration.

  2009cited by this paper
• Neural Stem Cells as a Novel Platform for Tumor-Specific Delivery of Therapeutic Antibodies

  2009cited by this paper
• Off-target effects of epidermal growth factor receptor antagonists mediate retinal ganglion cell disinhibited axon growth.

  2009cited by this paper
• The inhibitory effects of trastuzumab on corneal neovascularization.

  2009cited by this paper
• ErbB receptors modulation in different types of peripheral nerve regeneration

  2008cited by this paper
• PROLONGED TARGET DEPRIVATION REDUCES THE CAPACITY OF INJURED MOTONEURONS TO REGENERATE

  2007cited by this paper
• ErbB2 Signaling in Schwann Cells Is Mostly Dispensable for Maintenance of Myelinated Peripheral Nerves and Proliferation of Adult Schwann Cells after Injury

  2006cited by this paper
• Application and potential limitations of animal models utilized in the development of trastuzumab (Herceptin): a case study.

  2006cited by this paper
• Schwann Cells Express Motor and Sensory Phenotypes That Regulate Axon Regeneration

  2006cited by this paper
• EGFR Activation Mediates Inhibition of Axon Regeneration by Myelin and Chondroitin Sulfate Proteoglycans

  2005cited by this paper
• Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor.

  2004cited by this paper
• ErbB Transmembrane Tyrosine Kinase Receptors Are Expressed by Sensory and Motor Neurons Projecting into Sciatic Nerve

  2004cited by this paper
• Axonal Neuregulin-1 Regulates Myelin Sheath Thickness

  2004cited by this paper
• Glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor sustain the axonal regeneration of chronically axotomized motoneurons in vivo

  2003cited by this paper
• The deaf and the dumb: the biology of ErbB-2 and ErbB-3.

  2003cited by this paper
• The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors.

  2003influential reference
• Transforming growth factor‐β and forskolin attenuate the adverse effects of long‐term Schwann cell denervation on peripheral nerve regeneration in vivo

  2002cited by this paper
• Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha.

  2002cited by this paper
• A dose‐dependent facilitation and inhibition of peripheral nerve regeneration by brain‐derived neurotrophic factor

  2002cited by this paper
• Structure of the Extracellular Region of HER3 Reveals an Interdomain Tether

  2002cited by this paper
• Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth.

  2002cited by this paper
• A decline in glial cell-line-derived neurotrophic factor expression is associated with impaired regeneration after long-term Schwann cell denervation.

  2002cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• The ErbB signaling network: receptor heterodimerization in development and cancer

  2000cited by this paper
• Nerve Injury, Axonal Degeneration and Neural Regeneration: Basic Insights

  1999cited by this paper
• ErbB-1 and ErbB-2 Acquire Distinct Signaling Properties Dependent upon Their Dimerization Partner

  1998cited by this paper
• The expression of the low affinity nerve growth factor receptor in long‐term denervated Schwann cells

  1997cited by this paper
• Expression of Neuregulins and their Putative Receptors, ErbB2 and ErbB3, Is Induced during Wallerian Degeneration

  1997cited by this paper
• A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors

  1997cited by this paper
• Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

  1996cited by this paper
• Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

  1996cited by this paper
• ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.

  1996cited by this paper
• Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2.

  1995cited by this paper
• Humanization of an anti-p185HER2 antibody for human cancer therapy.

  1992cited by this paper
• Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product.

  1990cited by this paper
• Schwann cell mitosis in response to regenerating peripheral axons in vivo.

  1985influential reference
• SCHWANN CELL PROLIFERATION IN DEVELOPING MOUSE SCIATIC NERVE

  1967cited by this paper
• Estimation of nuclear population from microtome sections

  1946cited by this paper

• ErbB signaling in brain injury regeneration: Pathway interactions and therapeutic potential.

  2025cites this paper
• Tumor-infiltrating nerves: unraveling the role of cancer neuroscience in tumorigenesis, disease progression, and emerging therapies

  2025cites this paper
• Inhibition of ErbB2 mitigates secondary denervation after traumatic muscle injury

  2025cites this paper
• Satellite glial cell manipulation prior to axotomy enhances developing dorsal root ganglion central branch regrowth into the spinal cord

  2024cites this paper
• The epidermal growth factor receptor inhibitor gefitinib enhances in vitro and in vivo sensory axon regeneration and functional recovery following transection in a mouse median nerve injury model

  2024cites this paper
• Trastuzumab holds potential to accelerate spontaneous sensory reinnervation after free flap breast reconstruction: a proof of concept

  2024influential citation
• EGFR-Activated JAK2/STAT3 Pathway Confers Neuroprotection in Spinal Cord Ischemia–Reperfusion Injury: Evidence from High-Throughput Sequencing and Experimental Models

  2023cites this paper
• Response of terminal Schwann cells following volumetric muscle loss injury.

  2023cites this paper
• Exosome-Mediated miR-21 Was Involved in the Promotion of Structural and Functional Recovery Effect Produced by Electroacupuncture in Sciatic Nerve Injury

  2022cites this paper
• Enhanced sciatic nerve regeneration by relieving iron-overloading and organelle stress with the nanofibrous P(MMD-co-LA)/DFO conduits

  2022cites this paper
• Engineered Schwann Cell-Based Therapies for Injury Peripheral Nerve Reconstruction

  2022cites this paper
• The effect of trastuzumab on taxane-induced peripheral neuropathy in women with breast cancer: a population-based cohort study

  2022cites this paper
• Myelination, axonal loss and Schwann cell characteristics in axonal polyneuropathy compared to controls

  2021cites this paper
• Gene correlation network analysis to identify regulatory factors in sciatic nerve injury

  2021cites this paper
• Effective in vitro differentiation of adipose-derived stem cells into Schwann-like cells with folic acid supplementation.

  2021cites this paper
• Oxygen carrier in core-shell fibers synthesized by coaxial electrospinning enhances Schwann cell survival and nerve regeneration

  2020cites this paper
• Charcot-Marie-Tooth Type 2B: A New Phenotype Associated with a Novel RAB7A Mutation and Inhibited EGFR Degradation

  2020cites this paper
• ISSN : 2469-5866 Neuregulin in Health and Disease

  2019cites this paper
• Application of Schwann Cells in Neural Tissue Engineering

  2018cites this paper
• Osteoclasts control sensory neurons axonal growth through epidermal growth factor receptor signaling

  2018cites this paper
• Neuregulin in Health and Disease.

  2018cites this paper
• „Pathway protection“ – Verbesserte Motoneuron-Regeneration durch additive End-zu-Seit-Koaptation sensorischer Axone

  2018cites this paper
• Trastuzumab inhibits pituitary tumor cell growth modulating the TGFB/SMAD2/3 pathway.

  2018cites this paper
• High-throughput screen for compounds that modulate neurite growth of human induced pluripotent stem cell-derived neurons

  2018influential citation
• Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease

  2018cites this paper
• Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer

  2018cites this paper
• The Neuroprotective Effect of Ethanol Intoxication in Traumatic Brain Injury Is Associated with the Suppression of ErbB Signaling in Parvalbumin-Positive Interneurons

  2018influential citation
• Postinjury Induction of Activated ErbB2 Selectively Hyperactivates Denervated Schwann Cells and Promotes Robust Dorsal Root Axon Regeneration

  2017cites this paper